Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
NCT00240643
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
640
Enrollment
INDUSTRY
Sponsor class
Conditions
Fibrillation, Atrial
Atrial Fibrillation
Interventions
DRUG:
SB424323
Sponsor
GlaxoSmithKline